| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/23/1993 | US5189025 Administering amino acid mixture |
| 02/23/1993 | US5188945 Recovery process for antibiotics ll-e19020 alpha and beta |
| 02/23/1993 | US5188841 Sustained release pharmaceutical formulations |
| 02/23/1993 | US5188840 Slow-release pharmaceutical agent |
| 02/23/1993 | US5188839 Pharmaceutical compositions of cimetidine |
| 02/23/1993 | US5188836 Release in both the stomach and small intestines; multilayer coating |
| 02/23/1993 | US5188835 Intravaginal devices |
| 02/23/1993 | US5188833 Antibacterial quinolinecarboxylic acid derivatives; photostability, heat resistance |
| 02/23/1993 | US5188832 Agents directed against parasites of fishes and insects |
| 02/23/1993 | US5188830 Methods for thrombolytic therapy |
| 02/23/1993 | US5188826 Used for dry eye application, consists of crosslinked acrylic acid polymer, one or more demulcents and vasoconstrictors; administered to eye in drop or gel form and releases water |
| 02/23/1993 | US5188823 Antiperspirant formulations |
| 02/23/1993 | US5188817 Method of treatment for periodontitis |
| 02/23/1993 | CA2076573A1 Benzodioxane derivatives |
| 02/23/1993 | CA2076556A1 A method and intermediates for the preparation of 6-fluorobenzisothiazoles |
| 02/23/1993 | CA2076419A1 Fluoromacrolides having immunosuppressive activity |
| 02/23/1993 | CA1313875C 4-¬4-¬4-¬4-¬¬2-(2,4-difluorophenyl)-2-(1h-azolylmethyl)-1, 3-dioxolan-4-y1|methoxy|phenyl|-1-piperazinyl|phenyl| triazolones |
| 02/23/1993 | CA1313872C Acetamide derivatives of dihydro-2,3-phenyl-3 -benzofuran-2-one, processes for their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | CA1313871C Derivatives of (dihydro-2,3-oxo-2-benzofuranyl-3)-2- acetic acid, processes for their preparation and pharmaceutical compositions containing them |
| 02/23/1993 | CA1313870C Derivatives of morpholine and their preparation process |
| 02/23/1993 | CA1313868C Orally active nonaddicting analgesics |
| 02/23/1993 | CA1313867C Pentasaccharides |
| 02/23/1993 | CA1313823C Method of treating anxiety with tetrahydrobenz(c,d) indole-6-carboxamides |
| 02/23/1993 | CA1313822C Method for inhibiting the release of histamine |
| 02/23/1993 | CA1313821C Method for inhibiting bone resorption and collagenase release |
| 02/23/1993 | CA1313816C Anthelmintic active compound combinations |
| 02/22/1993 | CA2076509A1 Hexahydrobenzo[f]quinolinones |
| 02/22/1993 | CA2076479A1 Benzo ¬f| quinolinones |
| 02/22/1993 | CA2076431A1 Condensed pyrimidine derivative |
| 02/21/1993 | CA2076444A1 2,4-thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing same |
| 02/21/1993 | CA2076443A1 1-(alcoxybenzyl)piperazins amidic compounds, process for their preparation and pharmaceutical compositions containing same |
| 02/21/1993 | CA2073138A1 Use of 9,12,15-octadecatriene-6-ynoic acid |
| 02/20/1993 | CA2076311A1 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
| 02/18/1993 | WO1993003051A1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
| 02/18/1993 | WO1993003049A1 New ganglioside derivatives |
| 02/18/1993 | WO1993003048A1 Process for purifying pentostatin |
| 02/18/1993 | WO1993003041A1 Geneserine derivatives as cholinesterase inhibitors |
| 02/18/1993 | WO1993003037A1 Organic nitrates, methods for preparing same and use thereof for treating cardiovascular diseases |
| 02/18/1993 | WO1993003035A1 Anti-hiv drug |
| 02/18/1993 | WO1993003034A1 Quinazoline derivatives as acetylcholinesterase inhibitors |
| 02/18/1993 | WO1993003030A1 Quinoline derivatives as immunostimulants |
| 02/18/1993 | WO1993003029A1 (-) and (+) 10-(1-azabicyclo[2.2.2.]oct-3-yl-methyl)-10 h-phenothiazine quaternary ammonium derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/18/1993 | WO1993003028A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 02/18/1993 | WO1993003027A1 1,3-oxathiolane nucleoside analogues |
| 02/18/1993 | WO1993003022A1 Compounds and methods for inhibition of hiv and related viruses |
| 02/18/1993 | WO1993003018A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | WO1993003016A1 Benzimidazolone derivatives as 5-ht1a and 5-ht2 antagonists |
| 02/18/1993 | WO1993003015A1 Heteroalkoxy benzazepines |
| 02/18/1993 | WO1993003014A1 Dihydropyridine derivatives, and process for their preparation |
| 02/18/1993 | WO1993003012A1 Indole derivatives |
| 02/18/1993 | WO1993002999A1 Phenylalkanoic acid derivative, production thereof, and separation of optical isomers thereof |
| 02/18/1993 | WO1993002707A1 New anti-diarrheic agents |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002686A1 Gangliosides with immunosuppressive ceramide moieties |
| 02/18/1993 | WO1993002685A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same |
| 02/18/1993 | WO1993002683A1 Composition for curing proliferative skin diseases |
| 02/18/1993 | WO1993002681A1 Prostaglandin-e1 formulation |
| 02/18/1993 | WO1993002680A1 Defaunation method |
| 02/18/1993 | WO1993002679A1 Method of treating premenstrual syndrome by administration of an angiotensin converting enzyme inhibitor |
| 02/18/1993 | WO1993002678A1 Use of quinozilinederivatives as orexigenics |
| 02/18/1993 | WO1993002677A1 5-ht4 receptor antagonists |
| 02/18/1993 | WO1993002676A1 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor |
| 02/18/1993 | WO1993002673A1 Method of altering sphingolipid metabolism and detecting fumonisin ingestion and contamination |
| 02/18/1993 | WO1993002672A1 Use of di-tertiary butylhydroxyphenyl derivates for treating inflammatory gastrointestinal tract diseases |
| 02/18/1993 | WO1993002671A1 Retrovirus proliferation inhibitor |
| 02/18/1993 | WO1993002667A1 Pharmaceutical composition |
| 02/18/1993 | WO1993002662A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | WO1993002657A1 Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss |
| 02/18/1993 | WO1993002556A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | WO1993000095A3 Bicyclic fibrinogen antagonists |
| 02/18/1993 | WO1992022527A3 3-substituted pyrrolidine derivatives as calcium channel antagonists |
| 02/18/1993 | WO1992022299A3 Use of antiarrhythmic agents to lower cholesterol |
| 02/18/1993 | WO1992020651A3 N-(heteroaryl)-imidazolyl-alkenoic acids |
| 02/18/1993 | WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 02/18/1993 | WO1992014696A3 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 02/18/1993 | CA2115256A1 Phenylalkanoic acid derivatives, process for producing the same and process for separating optical isomers thereof |
| 02/18/1993 | CA2115250A1 Geneserine derivatives as cholinesterase inhibitors |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114844A1 (-) and (+) 10-(1-azabicyclo[2.2.2.]oct-3-yl-methyl)-10 h-phenothiazine quaternary ammonium derivatives, pharmaceutical compositions containing them and process for their preparation |
| 02/18/1993 | CA2114651A1 Furylthiazole and their use as h2-receptor antagonism and antimicrobial |
| 02/18/1993 | CA2114621A1 Compounds having angiotensine ii antagonistic activity |
| 02/18/1993 | CA2114216A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | CA2113990A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2113922A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
| 02/18/1993 | CA2113837A1 Anti-hiv agent |
| 02/18/1993 | CA2113443A1 Prostaglandin e1 formulation |
| 02/18/1993 | CA2113115A1 Quinazoline derivatives as acetylcholinesterase inhibitors |
| 02/18/1993 | CA2112704A1 The use of dioxapyrrolomycin as an antiparasitic agent and compositions useful therefor |
| 02/18/1993 | CA2111113A1 Plasmalopsychosines and plasmalocerebrosides and methods of treating neuronal diseases employing the same |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | EP0527687A2 Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/17/1993 | EP0527686A1 New cephalosporin derivatives |
| 02/17/1993 | EP0527646A1 New compounds named the adenophostins, their preparation and their therapeutic use |
| 02/17/1993 | EP0527638A1 Compositions comprising diltiazem in sustained release form and hydrochlorothiazide in immediate release form |
| 02/17/1993 | EP0527637A1 Spheroids containing dittiazem and a spheronizing agent |
| 02/17/1993 | EP0527624A2 Use of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor in the preparation of a pharmaceutical for treating congestive heart failure |
| 02/17/1993 | EP0527540A1 Medicament for the treatment of withdrawal symptoms |
| 02/17/1993 | EP0527534A1 Quinoline and azaquinoline angiotensin II antagonists |